Inicio › Cánceres de la sangre › California › Los Angeles
Ensayos clínicos de Cánceres de la sangre en Los Angeles, CA
17 estudios para Cánceres de la sangre buscan participantes en centros de Los Angeles y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
ReclutandoFase 3
- Quetzal Site 7, Los Angeles
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
ReclutandoFase 3
- UCLA - Hematology/Oncology - Administrative Office ( Site 0009), Los Angeles
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
ReclutandoFase 2
- UCLA Medical Center, Los Angeles
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
ReclutandoFase 3
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles, Los Angeles
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ReclutandoFase 1
- USC Norris Comprehensive Cancer Center, Los Angeles
- UCLA Health - Bowyer Oncology Center, Los Angeles
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
ReclutandoFase 1
- Cedars-Sinai Medical Center, Los Angeles
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
ReclutandoFase 1
- University of California, Los Angeles
Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant
ReclutandoFase 1
- Cedars-Sinai Medical Center, Los Angeles
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
ReclutandoFase 1
- START Los Angele, Los Angeles
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ReclutandoFase 2
- UCLA Department of Medicine, Los Angeles
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
ReclutandoEstudio observacional
- UCLA, Los Angeles
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
ReclutandoFase 3
- University of California LA, Los Angeles
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
ReclutandoFase 1
- USC / Norris Comprehensive Cancer Center, Los Angeles
- UCLA - Bowyer Oncology Center, Los Angeles
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
ReclutandoEstudio observacional
- University of Southern California - Norris Comprehensive Cancer Center, Los Angeles
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
ReclutandoFase 1/2
- Valkyrie Clinical Trials, Los Angeles
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
ReclutandoFase 1
- Children's Hospital Los Angeles, Los Angeles
Ensayos de Cánceres de la sangre en otras ciudades
- Houston, TX46 estudios
- New York City, NY26 estudios
- Boston, MA25 estudios
- Washington, DC19 estudios
- Baltimore, MD18 estudios
- Seattle, WA18 estudios
- Durham, NC16 estudios
- Chicago, IL15 estudios
- Philadelphia, PA14 estudios
- Columbus, OH14 estudios
- Edison, NJ13 estudios
- Baldwin Park, CA13 estudios
Otros estudios en Los Angeles
- Cáncer de pulmón de células no pequeñas87 estudios
- Cáncer (todos los tipos)74 estudios
- Cáncer de seno72 estudios
- Cáncer del colon y del recto60 estudios
- Cáncer de próstata60 estudios
- Cáncer metastásico57 estudios
- Cáncer de ovario50 estudios
- Cáncer de pulmón45 estudios
- Carcinoma de células escamosas de cabeza y cuello42 estudios
- Cáncer de páncreas35 estudios
- Melanoma34 estudios
- Cáncer de endometrio34 estudios
De ClinicalTrials.gov, datos obtenidos el 7 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.